Bumrungrad performed the latest minimally invasive procedure by water vapor therapy for Benign Prostatic Hyperplasia for the first time in Thailand.
At present, the number of the elderly has been rising, which raises health concerns among international public health organizations. One of the most common health problems in older males is Benign Prostatic Hyperplasia (BPH), which is found in 50% of men 50 and over and 70% of men 60 and over. An 85-year-old man would have a 90% chance of having BPH Usually, symptoms appear around of 50 years of age or older. The symptoms include difficulty urinating, frequent or urgent need to urinate especially at night, or inconsistent urine stream. These negatively impact their quality of life. The symptoms and severity of BPH vary, regardless of the size of the prostate.
Bumrungrad realizes the problem and has adopted the latest minimally invasive procedure by water vapor therapy for BPH for the first time in Thailand. This convenient, fastand minimally invasive procedure is appropriate for people who have trouble urinating resulting from BPH. The water vapor therapy
for Benign Prostatic Hyperplasia (BPH) has been approved by the U.S. Food and Drug Administration (FDA) since 2015. It is also approved by the Thai Food and Drug Administration in early 2021. Bumrungrad's Urology Center, one of our Centers of Excellence, strives to provide accurate diagnosis and immediate, effective treatments which meet international safety standards.
The virtual press conference led by Pharmacist Artirat Charukitpipat - Chief Executive Officer, Bumrungrad International Hospital, Dr. Viroj Chodchoy - Medical Director of the Urology Center and specialist in Urology, Bumrungrad International Hospital, Dr. Teerapon Amornvesukit, Dr. Charuspong Dissaranan, Dr. Jakkrit Issayanuwat - Urology Specialist (Genito-Urinary), Bumrungrad International Hospital and Suthichai Yoon as a special guest.